General Information
Revision date
2018-01-31
Product name
Human Peripheral Blood Plasma, Human Immunodeficiency Virus
Substance name
AND COMPANY INFORMATION
Icons in SDS
Company Information
company name
AND COMPANY INFORMATION
GHS Information
Signal word
Biohazard
Section 2
Signal word
Biohazard
Health hazards
For Biosafety Level 1 Handle as a potentially biohazardous material under at least Biosafety Level 1 containment. The donor(s) have been screened for Hepatitis B, human immunodeficiency viruses or other adventitious agents, unless otherwise reported on the Certificate of Analysis. Regardless of results reported on the Certificate of Analysis Universal Precautions according to 29 CFR 1910.1030 should be followed at all times when handling product. For Biosafety Level 2 Handle as a potentially biohazardous material under at least Biosafety Level 2 containment. These human source materials are associated with human disease, hazards include: percutaneous injury, ingestion, mucous membrane exposure (U.S. Government Publication Biosafety in Microbiological and Biomedical Laboratories). The donor(s) have been screened for Hepatitis B, human immunodeficiency viruses or other adventitious agents, unless otherwise reported on the Certificate of Analysis. Regardless of results reported on the Certificate of Analysis Universal Precautions according to 29 CFR 1910.1030 should be followed at all times when manipulating these cell lines. Host Range: Humans Infectious Dose: Unknown Mode of Transmission: HIV is transmitted from person to person through direct exposure to infected body fluids (blood, semen) sexual contact; by using contaminated needles etc.; or from mother to infant during pregnancy, delivery or breastfeeding. There are no obvious differences in disease manifestations in individuals infected by mucosal versus blood-borne routes. Incubation Period: Variable.
